Research and Development

Showing 15 posts of 9573 posts found.

astrazeneca_sign_sky

AstraZeneca’s lung cancer treatment approved in China

June 23, 2021 Research and Development

AstraZeneca and HUTCHMED’s savolitinib has been granted conditional approval in China for the treatment of patients with non-small cell lung …
european_commission_web

Extra 150 million doses of Moderna COVID jab bought by EC

June 23, 2021 Research and Development

Moderna have announced that the European Commission (EC) has purchased an additional 150 million doses of their COVID-19 vaccine, bringing …
janssen_latest_logo_on_sign_closer

EU approves Janssen’s treatments for amyloidosis and multiple myeloma

June 23, 2021 Research and Development

The EU has approved Janssen’s DARZALEX SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment …

Vectura announces cannabinoid company collaboration for TBI treatment

June 23, 2021 Research and Development

Vectura have announced the signing of a pre-clinical development agreement with Incannex, an Australian cannabinoid medicines development company, to provide …

UK COVID vaccine update

June 16, 2021 Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

June 16, 2021 Research and Development

The past week has seen quite a mixed bag when it comes to COVID-19 news, an AstraZeneca antibody has failed …

Ground-breaking COVID antibody treatment proven to save lives

June 16, 2021 Research and Development COVID-19, UK, antibodies, trial

Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …

Signite’s sustainable decorating solution to reduce label waste by 50%

June 16, 2021 Research and Development

ACTEGA has officially launched Signite, a new decorating solution designed to significantly reduce waste in label production. The hope is …

Avadel’s narcolepsy Phase III trial shows positive results

June 16, 2021 Research and Development

Avadel’s Phase III trial for FT218 in patients with narcolepsy has shown positive results. The data from the trial demonstrated …

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

The importance of representation in clinical trials

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …

Softbox brings in Sean Austerberry as new Director

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Softbox Systems has appointed Sean Austerberry as its Research and Product Development Director. Sean will be responsible for all of …
robert_obeirn

Sharp adds Robert O’Beirn to its Global Clinical Services Business

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sharp has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. In early 2019 Mr …
deb_hussain

Debra Hussain new CCO of Acacia Pharma

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Acacia Pharma has appointed Debra Hussain as Chief Commercial Officer. She is a highly experienced commercial leader having spent over …
natalie_berner

Redx installs Natalie Berner as Non-Executive Director

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Redx Pharma has appointed Natalie Berner as a Non- Executive Director, she will represent RM Special Holdings 3 LLP on …
The Gateway to Local Adoption Series

Latest content